ANG Lifesciences, a company in the Pharmaceuticals industry, reported revenue of ₹20 crore and a net loss of ₹2.09 crore for the September 2026 quarter.
ANG Lifesciences (BSE: ANG) closed at ₹37.16 on 20 Nov 2026, up 31.9% over the past year. Its market capitalisation is ₹49 crore.
Incorporated in 2006, ANG Lifesciences India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.